Stock Scorecard
Stock Summary for Applied Dna Sciences Inc (APDN) - $4.73 as of 6/19/2025 5:28:01 PM EST
Total Score
15 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for APDN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for APDN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for APDN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for APDN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for APDN (32 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 10 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 1 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for APDN
Financial Details for APDN
Company Overview |
|
|---|---|
| Ticker | APDN |
| Company Name | Applied Dna Sciences Inc |
| Country | USA |
| Description | Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the pre-clinical drug development and manufacturing markets based on nucleic acid-based in vitro diagnostics; and for supply chain security, anti-counterfeiting, and anti-theft technology applications in the United States, Europe, and Asia. The company is headquartered in Stony Brook, New York. |
| Sector Name | TRADE & SERVICES |
| Industry Name | SERVICES-MISCELLANEOUS BUSINESS SERVICES |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 4.73 |
| Price 4 Years Ago | 60,300.00 |
| Last Day Price Updated | 6/19/2025 5:28:01 PM EST |
| Last Day Volume | 21,525 |
| Average Daily Volume | 811,770 |
| 52-Week High | 2,655.00 |
| 52-Week Low | 4.37 |
| Last Price to 52 Week Low | 8.24% |
Valuation Measures |
|
| Trailing PE | 0.00 |
| Industry PE | 52.65 |
| Sector PE | 47.91 |
| 5-Year Average PE | -16,541.23 |
| Free Cash Flow Ratio | 0.36 |
| Industry Free Cash Flow Ratio | 63.69 |
| Sector Free Cash Flow Ratio | 59.56 |
| Current Ratio Most Recent Quarter | 4.45 |
| Total Cash Per Share | 13.15 |
| Book Value Per Share Most Recent Quarter | 24.78 |
| Price to Book Ratio | 0.24 |
| Industry Price to Book Ratio | 5.08 |
| Sector Price to Book Ratio | 10.78 |
| Price to Sales Ratio Twelve Trailing Months | 0.65 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.95 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.20 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 519,000 |
| Market Capitalization | 2,454,870 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.22% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 29.70% |
| Reported EPS 12 Trailing Months | 3,730.95 |
| Reported EPS Past Year | -15.95 |
| Reported EPS Prior Year | -5.24 |
| Net Income Twelve Trailing Months | -31,279,963 |
| Net Income Past Year | -6,992,521 |
| Net Income Prior Year | -9,947,059 |
| Quarterly Revenue Growth YOY | 5.80% |
| 5-Year Revenue Growth | -8.63% |
| Operating Margin Twelve Trailing Months | -352.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 6,823,260 |
| Total Cash Past Year | 6,431,095 |
| Total Cash Prior Year | 7,151,800 |
| Net Cash Position Most Recent Quarter | 6,823,260 |
| Net Cash Position Past Year | 6,431,095 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 2,345,903 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 9,142,617 |
| Total Stockholder Equity Prior Year | 4,951,159 |
| Total Stockholder Equity Most Recent Quarter | 10,224,208 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -13,950,108 |
| Free Cash Flow Per Share Twelve Trailing Months | -26.88 |
| Free Cash Flow Past Year | -14,119,301 |
| Free Cash Flow Prior Year | -6,296,125 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -2.39 |
| MACD Signal | -2.85 |
| 20-Day Bollinger Lower Band | -50.12 |
| 20-Day Bollinger Middle Band | 39.58 |
| 20-Day Bollinger Upper Band | 129.28 |
| Beta | 0.05 |
| RSI | 25.05 |
| 50-Day SMA | 12,053.57 |
| 150-Day SMA | 20.34 |
| 200-Day SMA | 21,402.71 |
System |
|
| Modified | 6/19/2025 5:28:03 PM EST |